Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares, rose in value on Thursday, March 27, with the stock price down by -3.24% to the previous day’s close as strong demand from buyers drove the stock to $5.97.
Actively observing the price movement in the last trading, the stock closed the session at $6.17, falling within a range of $5.95 and $6.3. The value of beta (5-year monthly) was 0.845. Referring to stock’s 52-week performance, its high was $12.36, and the low was $5.60. On the whole, RXRX has fluctuated by -28.42% over the past month.
With the market capitalization of Recursion Pharmaceuticals Inc currently standing at about $2.40 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-27.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 95.84M, with a low estimate of 6M and a high estimate of 34.3M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 18.12M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RXRX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of RXRX currently trading nearly -7.48% and -19.03% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.18, while the 7-day volatility ratio is showing 5.93% which for the 30-day chart, stands at 8.35%. Furthermore, Recursion Pharmaceuticals Inc (RXRX)’s beta value is 0.91, and its average true range (ATR) is 0.59.
A comparison of Recursion Pharmaceuticals Inc (RXRX) with its peers suggests the former has fared considerably weaker in the market. RXRX showed an intraday change of -3.24% in last session, and over the past year, it shrunk by -43.30%%.
Data on historical trading for Recursion Pharmaceuticals Inc (NASDAQ:RXRX) indicates that the trading volumes over the past 10 days have averaged 15.39 and over the past 3 months, they’ve averaged 23.13 million. According to company’s latest data on outstanding shares, there are 389.55 million shares outstanding.
Nearly 23.95% of Recursion Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 60.17% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 86.42 million shares as on 2025-03-14, resulting in a short ratio of 2.75. According to the data, the short interest in Recursion Pharmaceuticals Inc (RXRX) stood at 2338.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 75.45 million. The stock has fallen by -11.69% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RXRX stock heading into the next quarter.
